Target intelligence / Profile preview

HOXB cluster antisense RNA 2 (HOXB-AS2)

Target
HOXB-AS2
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT RNA)
01

Overview

**HOXB cluster antisense RNA 2 (HOXB-AS2)** is a long non-coding RNA (lncRNA) encoded within the HOXB gene cluster, overlapping the HOXB3 locus on the antisense (reverse) strand.[3] It is classified as a natural antisense transcript (NAT RNA). While some HOX cluster lncRNAs such as HOXA-AS2 and HOXA-AS3 are involved in cancer cell proliferation, apoptosis, and other regulatory pathways, the specific biological function of HOXB-AS2 remains poorly characterized. HOXB-AS2 has been proposed to play a regulatory role in gene expression and has been suggested to be *potentially* involved in the development of atrial fibrillation, but detailed mechanisms and targetability data are lacking.[3] It is not currently recognized as a validated therapeutic target and no drugs are reported to target HOXB-AS2. **Summary of interpretation:** - The most likely interpretation of your query is that you are interested in "HOXB-AS2," not "HOXA-AS2"—these are distinct lncRNAs from different HOX clusters. The available data specific to HOXB-AS2 is very limited, in contrast to HOXA-AS2, which is better studied in cancer biology.[1][2][3][4] If you intended HOXA-AS2, please clarify, as much more information is available. - HOXB-AS2 is not a receptor, enzyme, or characterized drug target; it is a lncRNA whose precise function and disease associations are still largely unknown. There are no known drug interactions, biomarkers, or detailed safety concerns reported in the literature.[3]

Other names
HOXB-AS2HOXB antisense RNA 2
02

Biological functions

Regulation of gene expression (potentially in cis or trans on HOXB genes)Potential role in regulation of cardiac rhythm (atrial fibrillation), based on association studies
03

Disease associations

Possible role in atrial fibrillationInsufficient evidence of a role in other diseases or as an established cancer biomarker/target

Beyond the preview

Go deeper on HOXB cluster antisense RNA 2 (HOXB-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOXB cluster antisense RNA 2 (HOXB-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call